Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)
ConditionSmoking Cessation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSouthcentral Foundation
About this trial
The purpose of this study is to refine and pilot an intervention using the Nicotine Metabolite Ratio (NMR) to inform the selection of pharmacologic treatment to increase smoking abstinence among Alaska Native and American Indian people. This is a single-arm pilot trial to assess and improve acceptability and feasibility.
Eligibility criteria
Qualifiers
Alaska Native or American Indian person by self-report
eligible for or already receiving services at Southcentral Foundation (SCF)
age 18 years or older
daily smoking in the past 30-days
Disqualifiers
Participated in the prior study phase
participated in a cessation program during the past 3 months
their provider has not approved varenicline in their referral to the Quit Tobacco Program
has history of serious hypersensitivity or skin reactions to varenicline
Trial design
Treatments tested in this trial
- Nicotine Metabolite Ratio
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Southcentral Foundation
Lead sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator
Source ClinicalTrials.gov